Y-box binding protein-1 expression in diffuse large B-cell lymphoma: an impact on prognosis in the rituximab era.

Hanzawa, Kyoko

Y-box binding protein-1 expression in diffuse large B-cell lymphoma: an impact on prognosis in the rituximab era. [electronic resource] - Leukemia & lymphoma Nov 2010 - 2054-62 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1029-2403

10.3109/10428194.2010.522285 doi


Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Antineoplastic Agents--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Pharmacological--metabolism
Biomarkers, Tumor--metabolism
Cyclophosphamide--therapeutic use
Doxorubicin--therapeutic use
Female
Humans
Lymphoma, Large B-Cell, Diffuse--diagnosis
Male
Middle Aged
Prednisone--therapeutic use
Prognosis
Rituximab
Survival Analysis
Vincristine--therapeutic use
Y-Box-Binding Protein 1--metabolism